Although it is also over-expressed in certain types of cancer, it is connected with a rather poor prognosis (except in prostate and ovarian cancers) in contrast to a generally better prognosis associated with a high expression of CCR2 (except in glioma, testicular, and renal cancers) due to the CCR3-mediated migration of cancer cells [26]. The gene discussed is CCR2; the disease is cancer.